Results of Phase I/II VMAT-TMI Dose Escalation Study Of Patients Undergoing Second Allogeneic Stem Cell Transplantation

被引：0
|
作者：
Partouche, J. [1 ]
Hasan, Y. [2 ]
Sullivan, M. [3 ]
Yenice, K. M. [4 ]
Stock, W. [3 ]
Larson, R. [3 ]
Artz, A. [5 ]
Bishop, M. [3 ]
Kosuri, S. [3 ]
Kline, J. [3 ]
Riedell, P. [3 ]
Liu, H. [3 ]
Aydogan, B. [1 ]
机构：
[1] Univ Chicago Med, Dept Radiat & Cellular Oncol, Chicago, IL USA
[2] Univ Chicago, Med Ctr, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA
[3] Univ Chicago Med, Chicago, IL USA
[4] Univ Chicago, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA
[5] City Hope Canc Ctr, Duarte, CA USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2020年 / 108卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3759
引用
收藏
页码：E757 / E757
页数：1
相关论文
共 50 条
  • [1] Romiplostim in Patients Undergoing Allogeneic Stem Cell Transplantation: Results of a Phase I/II Multicenter Trial
    de Latour, Regis Peffault
    Chevret, Sylvie
    Ruggeri, Annalisa
    Suarez, Felipe
    Souchet, Laetitia
    Michonneau, David
    de Fontbrune, Flore Sicre
    Coman, Tereza
    t Rubio, Marie
    Nguyen, Stephanie
    Mohty, Mohamad
    Socie, Gerard
    BLOOD, 2016, 128 (22)
  • [2] A Phase I Dose Escalation Study of Lenalidomide Following Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation
    Andritsos, Leslie A.
    Blum, William
    Klisovic, Rebecca B.
    Vasu, Sumithira
    Penza, Sam
    Lee, Jodi
    Marcucci, Guido
    Byrd, John C.
    Devine, Steven M.
    BLOOD, 2014, 124 (21)
  • [3] Total marrow irradiation (TMI) combined with treosulfan and fludarabine conditioning regimen for chemosensitive advanced multiple myeloma (MM) patients undergoing matched allogeneic stem-cell transplantation: First results of a phase I/II prospective monocentric study (TrRaMM TMI).
    Assanelli, Andrea A.
    Lorentino, Francesca
    Marcatti, Magda
    Chiara, Anna
    Teresa, Maria
    Stanghellini, Lupo
    Giglio, Fabio
    Clerici, Daniela
    Greco, Raffaella
    Broggi, Sara
    Cattaneo, Mauro
    Peccatori, Jacopo
    Ferreri, Andres J.
    Ciceri, Fabio
    Di Muzio, Nadia
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [4] Phase I dose escalation study of naive T-cell depleted donor lymphocyte infusion following allogeneic stem cell transplantation
    Ko K. Maung
    Benny J. Chen
    Ian Barak
    Zhiguo Li
    David A. Rizzieri
    Cristina Gasparetto
    Keith M. Sullivan
    Gwynn D. Long
    Ashley M. Engemann
    Barbara Waters-Pick
    Krista Rowe Nichols
    Richard Lopez
    Yubin Kang
    Stefanie Sarantopoulos
    Anthony D. Sung
    Nelson J. Chao
    Mitchell E. Horwitz
    Bone Marrow Transplantation, 2021, 56 : 137 - 143
  • [5] Dose Escalation of Total Marrow Irradiation in High-Risk Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
    Hui, Susanta
    Bronstein, Claudio
    Takahashi, Yutaka
    DeFor, Todd
    Holtan, Shernan G.
    Bachanova, Veronika
    Wilke, Christopher
    Zuro, Darren
    Ustun, Celalettin
    Weisdorf, Daniel
    Dusenbery, Kathryn
    Verneris, Michael R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (07) : 1110 - 1116
  • [6] Phase I dose escalation study of naive T-cell depleted donor lymphocyte infusion following allogeneic stem cell transplantation
    Maung, Ko K.
    Chen, Benny J.
    Barak, Ian
    Li, Zhiguo
    Rizzieri, David A.
    Gasparetto, Cristina
    Sullivan, Keith M.
    Long, Gwynn D.
    Engemann, Ashley M.
    Waters-Pick, Barbara
    Nichols, Krista Rowe
    Lopez, Richard
    Kang, Yubin
    Sarantopoulos, Stefanie
    Sung, Anthony D.
    Chao, Nelson J.
    Horwitz, Mitchell E.
    BONE MARROW TRANSPLANTATION, 2021, 56 (01) : 137 - 143
  • [7] Phase I, Dose Escalation Study of Naive T-Cell Depleted Donor Lymphocyte Infusion Following Allogeneic Stem Cell Transplantation
    Maung, Ko Ko
    Chen, Benny J.
    Rizzieri, David A.
    Gasparetto, Cristina
    Sullivan, Keith
    Long, Gwynn D.
    Engemann, Ashley Morris
    Waters-Pick, Barbara
    Nichols, Krista Rowe
    Lopez, Richard
    Kang, Yubin
    Sarantopoulos, Stefanie
    Sung, Anthony D.
    Chao, Nelson J.
    Horwitz, Mitchell E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [8] A Fructo-Oligosaccharide Prebiotic Is Well Tolerated in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Phase I Dose-Escalation Trial
    Andermann, Tessa M.
    Fouladi, Farnaz
    Tamburini, Fiona B.
    Sahaf, Bita
    Tkachenko, Ekaterina
    Greene, Courtney
    Buckley, Matthew T.
    Brooks, Erin F.
    Hedlin, Haley
    Arai, Sally
    Mackall, Crystal L.
    Miklos, David
    Negrin, Robert S.
    Fodor, Anthony A.
    Rezvani, Andrew R.
    Bhatt, Ami S.
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (11): : 932.e1 - 932.e11
  • [9] Psychosocial interventions for patients undergoing allogeneic stem cell transplantation: results of a controlled clinical study
    Grulke, N
    Bailer, H
    Juchems, A
    Heitz, V
    Caspari-Oberegelsbacher, H
    Domann, U
    Prudlo, U
    Kraus, S
    Larbig, W
    Kaechele, H
    PSYCHO-ONCOLOGY, 2003, 12 (04) : S219 - S219
  • [10] Phase I Study of the Safety and Pharmacokinetics of Plerixafor in Children Undergoing a Second Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory Leukemia
    Srinivasan, Ashok
    Panetta, John C.
    Cross, Shane J.
    Pillai, Asha
    Triplett, Brandon M.
    Shook, David R.
    Dallas, Mari H.
    Hartford, Christine
    Sunkara, Anusha
    Kang, Guolian
    Jacobsen, Jeffrey
    Choi, John
    Leung, Wing
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (08) : 1224 - 1228
12345